Understanding how young adults respond to rewards and cues related to addiction
Official title: Neurobehavioral signatures of sign- and goal-tracking in emerging adults: Translation of a preclinical model
Funded at University of Michigan at Ann Arbor · NIH-10796270 · Data updated 2026-11-12
This study is looking at how young adults respond to rewards and signals that might affect their chances of developing an addiction, and it aims to help identify those who may be at risk for substance use problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 30, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $686,809 |
| NIH project number | 1R01DA058010-01A1 |
| Project ID | NIH-10796270 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are emerging adults aged 18 to 24 who may be at risk for substance use disorders.
✕Less likely to help
Patients outside the age range of 18 to 24 or those with established substance use disorders may not benefit from this research.
What this research studies
This research investigates how emerging adults react to rewards and cues that may influence their risk of addiction. By using advanced neuroscience techniques, the study aims to identify specific neurobehavioral patterns associated with different types of reward tracking. Participants will engage in tasks designed to measure their responses to various incentives, helping researchers understand the underlying mechanisms of addiction liability. The findings could lead to better early identification of individuals at risk for substance use disorders.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing addiction in young adults.
How similar studies have gone: Previous research using animal models has shown success in understanding addiction mechanisms, but this approach in humans is relatively novel.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Cope, Lora M. — University of Michigan at Ann Arbor
- Study coordinator: Cope, Lora M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.